Fan Li, MD, MS, and Zhousheng Xiao, MD, PhD. “Fibroblast Growth Factor 23 As a Therapeutic Target”. Nephrology, Oct. 2018, pp. 16-21, doi:10.17140/NPOJ-4-118.